HIV/AIDS Therapy

Reports outline HIV/AIDS therapy research from L. Abramowitz and colleagues

Published in AIDS Weekly, August 24th, 2009

Research findings, 'Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients,' are discussed in a new report. According to a study from Paris, France, "Previous studies suggest a poor prognosis of epidermoid anal cancer in HIV+ patients. To investigate the long-term outcome of epidermoid anal cancer in HIV+ and HIV-patients in the highly active antiretroviral treatment (HAART) era."

"We included all patients with epidermoid anal cancer referred to six hospitals from 1998 to 2004. In all, 151 patients (44 HIV+, 107 HIV-) were reviewed retrospectively for 27 (median of 16-44) months. HIV+ patients were male (100% vs. 27%, p<0.001) and younger (45 vs. 62...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2009-08-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry